Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070

被引:374
|
作者
Soerjomataram, Isabelle [1 ]
Bray, Freddie [1 ]
机构
[1] Int Agcy Res Canc, Canc Surveillance Branch, Lyon, France
关键词
HEALTH IMPACT ASSESSMENT; MIDDLE-INCOME COUNTRIES; CERVICAL-CANCER; HUMAN-PAPILLOMAVIRUS; NORDIC COUNTRIES; COST-EFFECTIVENESS; TOBACCO CONTROL; BREAST-CANCER; FUTURE BURDEN; YOUNG-ADULTS;
D O I
10.1038/s41571-021-00514-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Assuming that the latest incidence trends continue for the major cancer types, the incidence of all cancers combined will double by 2070 relative to 2020, with the greatest increases predicted in lower-resource settings. The authors of this Perspective discuss how population-level approaches with amenable goals should be considered an integral part of cancer control. Cancer is currently the first or second most common contributor to premature mortality in most countries of the world. The global number of patients with cancer is expected to rise over the next 50 years owing to the strong influence of demographic changes, such as population ageing and growth, on the diverging trends in cancer incidence in different regions. Assuming that the latest incidence trends continue for the major cancer types, we predict a doubling of the incidence of all cancers combined by 2070 relative to 2020. The greatest increases are predicted in lower-resource settings, in countries currently assigned a low Human Development Index (HDI), whereas the predicted increases in national burden diminish with increasing levels of national HDI. Herein, we assess studies modelling the future burden of cancer that underscore how comprehensive cancer prevention strategies can markedly reduce the prevalence of major risk factors and, in so doing, the number of future cancer cases. Focusing on an in-depth assessment of prevention strategies that target tobacco smoking, overweight and obesity, and human papillomavirus infection, we discuss how stepwise, population-level approaches with amenable goals can avert millions of future cancer diagnoses worldwide. In the absence of a step-change in cancer prevention delivery, tobacco smoking will remain the leading preventable cause of cancer, and overweight and obesity might well present a comparable opportunity for prevention, given its increasing prevalence globally in the past few decades. Countries must therefore instigate national cancer control programmes aimed at preventing cancer, and with some urgency, if such programmes are to yield the desired public health and economic benefits in this century.
引用
收藏
页码:663 / 672
页数:10
相关论文
共 33 条
  • [1] Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070
    Isabelle Soerjomataram
    Freddie Bray
    [J]. Nature Reviews Clinical Oncology, 2021, 18 : 663 - 672
  • [2] Global patterns in testicular cancer incidence and mortality in 2020
    Znaor, Ariana
    Skakkebaek, Niels Erik
    Meyts, Ewa Rajpert-De
    Kulis, Tomislav
    Laversanne, Mathieu
    Gurney, Jason
    Sarfati, Diana
    McGlynn, Katherine A.
    Bray, Freddie
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (05) : 692 - 698
  • [3] The role of genomics in global cancer prevention
    Ginsburg, Ophira
    Ashton-Prolla, Patricia
    Cantor, Anna
    Mariosa, Daniela
    Brennan, Paul
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (02) : 116 - 128
  • [4] The role of genomics in global cancer prevention
    Ophira Ginsburg
    Patricia Ashton-Prolla
    Anna Cantor
    Daniela Mariosa
    Paul Brennan
    [J]. Nature Reviews Clinical Oncology, 2021, 18 : 116 - 128
  • [5] INCIDENCE OF LIVER CANCER BY HISTOLOGICAL SUBTYPES IN 2020: A GLOBAL STUDY
    Huang, Junjie
    Lok, Veeleah
    Zhang, Lin
    Lucero-Prisno, Don Eliseo, III
    Xu, Wanghong
    Zheng, Zhi-Jie
    Elcarte, Edmar
    Withers, Mellissa
    Wong, Martin
    [J]. GUT, 2022, 71 : A98 - A98
  • [6] The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040
    Zhang, Yanting
    Rumgay, Harriet
    Li, Mengmeng
    Yu, Haibing
    Pan, Haiyan
    Ni, Jindong
    [J]. JOURNAL OF GLOBAL HEALTH, 2023, 13
  • [7] Differences in the incidence and mortality of digestive cancer between Global Cancer Observatory 2020 and Global Burden of Disease 2019
    Yu, Ziqing
    Bai, Xiaoyin
    Zhou, Runing
    Ruan, Gechong
    Guo, Mingyue
    Han, Wei
    Jiang, Shiyu
    Yang, Hong
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (04) : 615 - 625
  • [8] GLOBAL INCIDENCE OF OESOPHAGEAL CANCER BY HISTOLOGICAL SUBTYPES IN 2020: A SYSTEMATIC ANALYSIS OF REGISTRIES
    Huang, Junjie
    Lok, Veeleah
    Zhang, Lin
    Lucero-Prisno, Don Eliseo
    Xu, Wanghong
    Zheng, Zhi-Jie
    Elcarte, Edmar
    Withers, Mellissa
    Wong, Martin
    [J]. GUT, 2022, 71 : A152 - A152
  • [9] Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative
    Singh, Deependra
    Vignat, Jerome
    Lorenzoni, Valentina
    Eslahi, Marzieh
    Ginsburg, Ophira
    Lauby-Secretan, Beatrice
    Arbyn, Marc
    Basu, Partha
    Bray, Freddie
    Vaccarella, Salvatore
    [J]. LANCET GLOBAL HEALTH, 2023, 11 (02): : E197 - E206
  • [10] Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050
    Rajesh Sharma
    [J]. International Journal of Clinical Oncology, 2022, 27 : 665 - 675